Grill, J., Geoerger, B., Gesner, L., Perek, D., Leblond, P., Cañete, A., . . . Hargrave, D. (2013). Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: A joint ITCC and SIOPE brain tumor study. Oxford University Press.
Citação norma ChicagoGrill, Jacques, et al. Phase II Study of Irinotecan in Combination With Temozolomide (TEMIRI) in Children With Recurrent or Refractory Medulloblastoma: A Joint ITCC and SIOPE Brain Tumor Study. Oxford University Press, 2013.
Citação norma MLAGrill, Jacques, et al. Phase II Study of Irinotecan in Combination With Temozolomide (TEMIRI) in Children With Recurrent or Refractory Medulloblastoma: A Joint ITCC and SIOPE Brain Tumor Study. Oxford University Press, 2013.